Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.60 and traded as low as $0.5225. Elite Pharmaceuticals shares last traded at $0.5321, with a volume of 291,637 shares trading hands.
Elite Pharmaceuticals Stock Up 0.9%
The company has a current ratio of 7.23, a quick ratio of 5.44 and a debt-to-equity ratio of 0.09. The firm has a market cap of $571.63 million, a P/E ratio of -53.21 and a beta of 0.10. The stock’s fifty day moving average is $0.61 and its two-hundred day moving average is $0.60.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Stories
- Five stocks we like better than Elite Pharmaceuticals
- How to Most Effectively Use the MarketBeat Earnings Screener
- Power On: Applied Digital’s First AI Data Center Goes Live
- What is a Bond Market Holiday? How to Invest and Trade
- Alphabet: The AI Leader Best Positioned to Dominate 2026
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 2 Reasons to Load Up on Fiserv, 1 to Stay Away
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
